Trial Outcomes & Findings for Spinal Cord Injury Program in Exercise (NCT NCT03925077)

NCT ID: NCT03925077

Last Updated: 2026-02-05

Results Overview

Physical activity was assessed using the Leisure Time Physical Activity Questionnaire for People with Spinal Cord Injury (LTPAQ-SCI). The LTPAQ-SCI is a 3-item, self-report questionnaire that measures the minutes people with spinal cord injury spend in mild, moderate, and heavy intensity leisure time physical activity in the last 7 days.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

96 participants

Primary outcome timeframe

Post 8-week intervention

Results posted on

2026-02-05

Participant Flow

Participants were recruited through social media platforms (e.g., Instagram, Facebook) and word of mouth. Recruitment for the Feasibility Phase took place between February 2021 and March 2022. Recruitment for the Effectiveness Phase occurred between August 2023 and September 2024. Recruitment and enrollment for both study phases were performed separately.

In the Feasibility Phase, the 36 enrolled participants were randomized to 3 groups: M2M, SET, and AC. For the Effectiveness Phase, the M2M arm was dropped after interim analysis and the 60 enrolled participants were randomized to 2 groups: SET and AC.

Participant milestones

Participant milestones
Measure
Phase 1: Movement-to-Music (M2M)
All M2M sessions are delivered using videos uploaded to a secure study website (the SCIPE website). Participants in M2M will have access to the website and attend three 60-minute M2M sessions per week for a total of 8 weeks. Each session provides rhythmic-based exercises that are choreographed to music to target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in M2M will receive and read weekly educational articles on health and fitness through the SCIPE website. Movement-to-Music: The M2M program has been developed for onsite instruction and will be repurposed into an eHealth version. The program is based on the positive effects of exercise and music on both physiological and psychosocial outcomes in people with disabilities. Investigators aim to advance our current M2M program by enabling more robust personalization features, allowing people with SCI to individualize their M2M program. Movement and tempo-based adaptations will also be available. A typical M2M session will consist of tailored movement routines starting with a warmup using range of motion exercises, followed by muscle strengthening, cardiorespiratory, and/or balance routines, and ending with a cool down emphasizing breathing and mindfulness.
Phase 1: Standard Exercise Training (SET)
All SET sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in SET will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training: The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 1: Attention Control (AC)
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Phase 2: Standard Exercise Training (SET)
All SET sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in SET will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training: The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 2: Attention Control (AC)
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Feasibility Phase
STARTED
12
12
12
0
0
Feasibility Phase
8-week Assessment
8
10
10
0
0
Feasibility Phase
12-week Assessment
5
8
9
0
0
Feasibility Phase
16-week Assessment
5
8
8
0
0
Feasibility Phase
COMPLETED
5
8
8
0
0
Feasibility Phase
NOT COMPLETED
7
4
4
0
0
Effectiveness Phase
STARTED
0
0
0
30
30
Effectiveness Phase
8-week Assessment
0
0
0
19
23
Effectiveness Phase
12-week Assessment
0
0
0
22
22
Effectiveness Phase
16-week Assessment
0
0
0
21
22
Effectiveness Phase
COMPLETED
0
0
0
21
22
Effectiveness Phase
NOT COMPLETED
0
0
0
9
8

Reasons for withdrawal

Reasons for withdrawal
Measure
Phase 1: Movement-to-Music (M2M)
All M2M sessions are delivered using videos uploaded to a secure study website (the SCIPE website). Participants in M2M will have access to the website and attend three 60-minute M2M sessions per week for a total of 8 weeks. Each session provides rhythmic-based exercises that are choreographed to music to target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in M2M will receive and read weekly educational articles on health and fitness through the SCIPE website. Movement-to-Music: The M2M program has been developed for onsite instruction and will be repurposed into an eHealth version. The program is based on the positive effects of exercise and music on both physiological and psychosocial outcomes in people with disabilities. Investigators aim to advance our current M2M program by enabling more robust personalization features, allowing people with SCI to individualize their M2M program. Movement and tempo-based adaptations will also be available. A typical M2M session will consist of tailored movement routines starting with a warmup using range of motion exercises, followed by muscle strengthening, cardiorespiratory, and/or balance routines, and ending with a cool down emphasizing breathing and mindfulness.
Phase 1: Standard Exercise Training (SET)
All SET sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in SET will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training: The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 1: Attention Control (AC)
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Phase 2: Standard Exercise Training (SET)
All SET sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in SET will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training: The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 2: Attention Control (AC)
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Feasibility Phase
Lost to Follow-up
7
4
4
0
0
Effectiveness Phase
Lost to Follow-up
0
0
0
9
8

Baseline Characteristics

In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Phase 1: Movement-to-Music (M2M)
n=12 Participants
All M2M sessions are delivered using videos uploaded to a secure study website (the SCIPE website). Participants in M2M will have access to the website and attend three 60-minute M2M sessions per week for a total of 8 weeks. Each session provides rhythmic-based exercises that are choreographed to music to target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in M2M will receive and read weekly educational articles on health and fitness through the SCIPE website. Movement-to-Music (M2M): The M2M program has been developed for onsite instruction and will be repurposed into an eHealth version. The program is based on the positive effects of exercise and music on both physiological and psychosocial outcomes in people with disabilities. Investigators aim to advance our current M2M program by enabling more robust personalization features, allowing people with SCI to individualize their M2M program. Movement and tempo-based adaptations will also be available. A typical M2M session will consist of tailored movement routines starting with a warmup using range of motion exercises, followed by muscle strengthening, cardiorespiratory, and/or balance routines, and ending with a cool down emphasizing breathing and mindfulness.
Phase 1: Standard Exercise Training (SET)
n=12 Participants
All SET sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in SET will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training (SET): The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 1: Attention Control (AC)
n=12 Participants
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Phase 2: Standard Exercise Training (SET)
n=30 Participants
Standard Exercise Training (SET): The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 2: Attention Control (AC)
n=30 Participants
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Total
n=96 Participants
Total of all reporting groups
Age, Continuous
42.0 Years
STANDARD_DEVIATION 11.6 • n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
47.7 Years
STANDARD_DEVIATION 11.8 • n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
46.4 Years
STANDARD_DEVIATION 12.0 • n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
49.5 Years
STANDARD_DEVIATION 10.8 • n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
47.3 Years
STANDARD_DEVIATION 12.3 • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
47.3 Years
STANDARD_DEVIATION 11.6 • n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Sex: Female, Male
Female
6 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
5 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
8 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
20 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
17 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
56 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Sex: Female, Male
Male
6 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
7 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
4 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
10 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
13 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
40 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
1 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
2 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
4 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
2 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
10 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
11 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
9 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
26 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
28 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
85 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
1 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
1 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
2 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
2 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Race (NIH/OMB)
Asian
1 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
1 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
2 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Race (NIH/OMB)
Black or African American
1 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
2 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
2 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
7 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
6 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
18 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Race (NIH/OMB)
White
10 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
10 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
6 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
20 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
22 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
68 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Race (NIH/OMB)
More than one race
0 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
3 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
3 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=41 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=1581 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
2 Participants
n=4626 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
0 Participants
n=72 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
1 Participants
In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.
3 Participants
n=140 Participants • In Feasibility phase, there were three study arms (M2M, SET, and AC) with 36 participants randomized and participated. In the Effectiveness phase, the M2M arm was removed. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. We report the baseline characteristics of participants in the Effectiveness phase here.

PRIMARY outcome

Timeframe: Post 8-week intervention

Population: We report outcomes collected for the Effectiveness phase here. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. The M2M arm was removed per approval and participants enrolled in the Effectiveness phase were randomized to SET or AC.

Physical activity was assessed using the Leisure Time Physical Activity Questionnaire for People with Spinal Cord Injury (LTPAQ-SCI). The LTPAQ-SCI is a 3-item, self-report questionnaire that measures the minutes people with spinal cord injury spend in mild, moderate, and heavy intensity leisure time physical activity in the last 7 days.

Outcome measures

Outcome measures
Measure
Phase 2: Standard Exercise Training (SET)
n=20 Participants
All M2M sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in M2M will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training: The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 2: Attention Control (AC)
n=21 Participants
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Physical Activity Level at Week 8
383 Minutes per week
Standard Deviation 347
297 Minutes per week
Standard Deviation 227

SECONDARY outcome

Timeframe: Post 8-week intervention

Population: We report outcomes collected for the Effectiveness phase here. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. The M2M arm was removed per approval and participants enrolled in the Effectiveness phase were randomized to SET or AC.

The pain intensity was assessed using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Pain Intensity Adult Short Form 3a (v1.0). The instrument is a 3-item measure with the response scores ranging from 1 (Had no pain) to 5 (Very severe). The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis. Higher scores indicate higher pain intensity.

Outcome measures

Outcome measures
Measure
Phase 2: Standard Exercise Training (SET)
n=20 Participants
All M2M sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in M2M will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training: The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 2: Attention Control (AC)
n=23 Participants
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Pain Intensity Week 8
53.5 T-score
Standard Deviation 10.6
56.3 T-score
Standard Deviation 9.9

SECONDARY outcome

Timeframe: Post 8-week intervention

Population: We report outcomes collected for the Effectiveness phase here. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. The M2M arm was removed per approval and participants enrolled in the Effectiveness phase were randomized to SET or AC.

The influence of pain on performing daily activities was assessed with the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Pain Interference Adult Short Form 8a (v1.0). The form contains 8 items with 5 response options ranging from 1 (Not at all) to 5 (Very much). The form has raw scores range from 8 to 40, with higher scores indicating more pain interference. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

Outcome measures

Outcome measures
Measure
Phase 2: Standard Exercise Training (SET)
n=20 Participants
All M2M sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in M2M will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training: The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 2: Attention Control (AC)
n=23 Participants
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Pain Interference at Week 8
53.6 T-score
Standard Deviation 8.5
55.5 T-score
Standard Deviation 8.9

SECONDARY outcome

Timeframe: Post 8 week intervention

Population: We report outcomes collected for the Effectiveness phase here. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. The M2M arm was removed per approval and participants enrolled in the Effectiveness phase were randomized to SET or AC.

Sleep quality is assessed using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Sleep Disturbance Adult Short Form 8a, which contains 8 items on a 5-point Likert scale, ranging from 1 (Very much) to 5 (Not at all). The form has raw scores range from 8 to 40, with higher scores indicating worst sleep quality. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

Outcome measures

Outcome measures
Measure
Phase 2: Standard Exercise Training (SET)
n=20 Participants
All M2M sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in M2M will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training: The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 2: Attention Control (AC)
n=23 Participants
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Sleep Quality at Week 8
51.7 T-score
Standard Deviation 5.6
52.7 T-score
Standard Deviation 5.6

SECONDARY outcome

Timeframe: Post 8-week intervention

Population: We report outcomes collected for the Effectiveness phase here. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. The M2M arm was removed per approval and participants enrolled in the Effectiveness phase were randomized to SET or AC.

Fatigue was measured using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Fatigue Adult Short Form. The instrument is a 8 items on a 5-point Likert scale, ranging from 1 (Not at all/Never) to 5 (Very much/Always). Higher scores indicate higher fatigue. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

Outcome measures

Outcome measures
Measure
Phase 2: Standard Exercise Training (SET)
n=20 Participants
All M2M sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in M2M will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training: The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 2: Attention Control (AC)
n=23 Participants
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Fatigue Level at Week 8
50.1 T-score
Standard Deviation 10.5
55.1 T-score
Standard Deviation 9.7

SECONDARY outcome

Timeframe: Post 8-week intervention

Population: We report outcomes collected for the Effectiveness phase here. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. The M2M arm was removed per approval and participants enrolled in the Effectiveness phase were randomized to SET or AC.

Health-related quality of life was assessed using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) 10 Global Health Items. The Global-10 Health form is a 10-item measure with the response scores ranging from 1 (Poor/Not at all/Always/Very severe) to 5 (Excellent/Completely/Never/None). One question item, "how would you rate your pain on average?", is on a 11-point Likert scale that ranges from 0 (No pain) to 10 (Worst pain imaginable). Higher scores indicate better health-related quality of life. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.

Outcome measures

Outcome measures
Measure
Phase 2: Standard Exercise Training (SET)
n=20 Participants
All M2M sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in M2M will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training: The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 2: Attention Control (AC)
n=23 Participants
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Health-related Physical Quality of Life at Week 8
43.6 T-score
Standard Deviation 8.5
41.3 T-score
Standard Deviation 6.8

SECONDARY outcome

Timeframe: Post 8-week intervention

Population: We report outcomes collected for the Effectiveness phase here. The goal of the Effectiveness phase was to compare the effectiveness between SET and AC. The M2M arm was removed per approval and participants enrolled in the Effectiveness phase were randomized to SET or AC.

Social participation was measured using the NIH Patient-Reported Outcomes Measurement Information System (PROMIS®) Ability to Participate in Social Roles and Activities Short Form 8a. The instrument is a 8-item measure with the response scores ranging from 1 (always) to 5 (never). The lowest possible total raw score is 8 and the highest possible score is 40. Higher scores indicate better ability to participate in social roles and activities. The total raw score is converted to a T-score (population mean=50, SD=10) using standard scoring guidelines for each participant for analysis.each participant for analysis.

Outcome measures

Outcome measures
Measure
Phase 2: Standard Exercise Training (SET)
n=20 Participants
All M2M sessions are delivered using videos uploaded to the SCIPE website. Participants in SET will have access to the website and attend three 60-minute SET sessions per week for a total of 8 weeks. Each session provides traditional exercises that target range of motion, muscular strength, cardiorespiratory fitness, and balance. In addition, participants in M2M will receive and read weekly educational articles on health and fitness through the SCIPE website. Standard Exercise Training: The SET program is based on the NCHPAD 14-Weeks to a Healthier You program launched in 2008. Exercise videos including range of motion, muscle strengthening, cardio and balance routines performed both seated and standing have been developed and will be restructured for use in this study. The SET program will be delivered through the same platform as M2M.
Phase 2: Attention Control (AC)
n=23 Participants
Participants in AC will not have access to any exercise videos. They will have access to the weekly educational articles on health and fitness, same as the ones received by the M2M and SET groups, through the SCIPE website.
Ability to Participate in Social Roles and Activities at Week 8
50.3 T-score
Standard Deviation 9.0
45.4 T-score
Standard Deviation 9.4

Adverse Events

Phase 1: Movement-to-Music (M2M)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Phase 1: Standard Exercise Training (SET)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Phase 1: Attention Control (AC)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Phase 2: Standard Exercise Training (SET)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Phase 2: Attention Control (AC)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Hui-Ju Young

University of Alabama at Birmingham

Phone: 2059341168

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place